BRIEF published on 07/31/2024 at 22:30, 2 years 1 month ago Kidoz Thrives as COPPA 2.0 Approved by US Senate Forcing Platforms to Adopt Safe Advertising for Under 17s Online Online Privacy Kidoz Inc. Child Safety COPPA 2.0 Contextual Advertising
BRIEF published on 07/31/2024 at 22:30, 2 years 1 month ago Kidoz prospère grâce à l'approbation de la COPPA 2.0 par le Sénat américain, obligeant les plateformes à adopter une publicité sécurisée pour les moins de 17 ans en ligne Kidoz Inc. Confidentialité En Ligne La Sécurité Des Enfants COPPA2.0 Publicité Contextuelle
BRIEF published on 07/31/2024 at 22:10, 2 years 1 month ago Nexera Energy Increases Private Placement Offering to $775,000 Private Placement Fundraising Texas Oil And Gas Nexera Energy
BRIEF published on 07/31/2024 at 22:10, 2 years 1 month ago Nexera Énergie augmente son placement privé à 775 000 $ Texas Placement Privé Pétrole Et Gaz Collecte De Fonds Nexera Énergie
BRIEF published on 07/31/2024 at 22:05, 2 years 1 month ago Inventiva Reports Preliminary 2024 First-Half Financial Information Financial Results Revenue Inventiva H1 2024 R&D Expenses
BRIEF published on 07/31/2024 at 22:05, 2 years 1 month ago Inventiva publie ses informations financières préliminaires pour le premier semestre 2024 Résultats Financiers Revenu Inventive S1 2024 Dépenses De R&D
BRIEF published on 07/31/2024 at 21:30, 2 years 1 month ago All-In Nutritionals Implements Art and Science in Formulating Natural Health Supplements Health And Wellness Organic Products Natural Supplements Ingredient Formulation Synergistic Effects
BRIEF published on 07/31/2024 at 21:30, 2 years 1 month ago All-In Nutritionals met en œuvre l'art et la science dans la formulation de suppléments de santé naturels Santé Et Bien-être Produits Bio Suppléments Naturels Formulation Des Ingrédients Effets Synergiques
BRIEF published on 07/31/2024 at 21:08, 2 years 1 month ago EUROBIO SCIENTIFIC: Agreement for a Voluntary Tender Offer In Vitro Diagnostics Tender Offer Eurobio Scientific IK Partners NextStage AM
BRIEF published on 07/31/2024 at 21:08, 2 years 1 month ago EUROBIO SCIENTIFIC : Accord d'offre publique d'achat volontaire Offre Publique D'achat Diagnostic In Vitro Eurobio Scientifique Partenaires CI Étape Suivante AM
Published on 09/11/2026 at 23:00, 42 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 hour 37 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 hours 17 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 6 hours 42 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 6 hours 42 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 1 hour 26 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 hour 31 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 57 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 5 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 16 hours 42 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 16 hours 42 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 16 hours 42 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 16 hours 42 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 4 hours ago Availability of the 2026 Interim Financial Report
